There were no differences in plasma CLDN-1 concentrations among these groups: the medians of plasma CLDN-1 concentrations were 0.01, 0.00, and 0.00 ng/mL in the control, MCI, and AD groups, respectively (Figure 2C). This evidence concerns the gene CLDN1 and Alzheimer disease.